T1	Participants 104 118	COPD patients.
T2	Participants 214 271	smokers with chronic obstructive pulmonary disease (COPD)
T3	Participants 469 486	COPD participants
T4	Participants 579 679	smokers with mild-to-moderate COPD were treated with varenicline 1 mg b.i.d. or placebo for 12 weeks
